Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 28, 2026Allergy Asthma and Clinical ImmunologyOpen Access

Real world outcomes of iodinated contrast media re-exposure in Chinese patients with prior hypersensitivity

View Full Paper
Ask AI
Bookmark
Share

Authors

SBSainan BianLLLun LiLCLe Cui

Discussion

Loading...

Member takes

Overview

Retrospective study demonstrates a 9.2% reaction recurrence during contrast re-exposure in hypersensitive patients, suggesting combining contrast switching with premedication prevents recurrent...

Key Points

  • To evaluate clinical outcomes and recurrence rates in patients with a history of iodinated contrast medium-induced hypersensitivity reactions who undergo contrast re-exposure.
  • Retrospectively reviewed medical records of inpatients receiving allergy consultations at Peking Union Medical College Hospital between January 1, 2019, and July 31, 2024.
  • Enrolled 65 patients (47 males, 72.3%; mean age 59.6 ± 16.1 years) with documented prior contrast hypersensitivity who subsequently received iodinated contrast media re-administration.
  • Assessed preventive management strategies, including contrast medium switching (50.8%) and premedication administration (84.6%).
  • Recurrent hypersensitivity reactions occurred in 9.2% of patients (6/65; 2 immediate, 4 non-immediate), while 90.8% (59/65) had no reaction recurrence upon re-exposure.
  • Prior non-immediate hypersensitivity was significantly more prevalent among patients experiencing recurrence compared with those who did not (100% vs. 52.5%, P = 0.025).
  • Recurrence rates were lowest with contrast switching combined with premedication (0.0%) compared with premedication alone (33.3%) and contrast switching alone (14.3%, P = 0.021).

Cite This Study

Bian et al. (2026) studied this question.

synapsesocial.com/papers/6a914622d15324a1df3a97d2https://doi.org/10.1186/s13223-026-01058-6
View Full Paper
Ask AI
Bookmark
Share